Hot Selling Quiet Nebulizador Machine Portable Home Jet Piston Compressor Nebulizer

Description

Shenzhen Fitconn Technology Co.,ltd was founded in 2012 . It is a comprehensive enterprise dedicated to the research and development, manufacturing, sales and after-sales service of household medical products. The products cover nebulizer (compressor nebulizer, DC Compressor nebulizer and Mesh nebulizer), anti-decubitus air mattress, oximeters, fetal doppler, blood pressure monitors, etc. The business covers more than 150 countries around the world, with an average annual service of more than 2,000,000 family. Fitconn adheres to the concept of create health by heart, and is committed to improving the diversification of atomization methods, let’s households medical products and modern medical technology can benefit thousands of families around the world, with respect, tolerance, integrity, efficiency, innovation and persistence as core values, Integrate superior resources, take innovation as the source of development, and take science and technology as the foundation of success, and strive to provide each consumer with more professional, advanced and safer medical products. Fitconn has the class II medical device production qualification and over 50 patents , the company has passed the 13485 quality system certification, and some products have passed the EU CE and FDA certification

Fitconn CNB69006: One Nebulizer, Five Regulatory Jurisdictions

Ask any medical device importer what actually slows down a product launch, and the answer is rarely manufacturing. It is registration. A nebulizer that clears CE marking still needs separate ANVISA registration to enter Brazil, MHRA registration for the post-Brexit UK market, and NMPA approval for China. Each pathway carries its own testing requirements, documentation package, local representative obligations, and timeline measured in months.

The Fitconn CNB69006 arrives with all of them already in place. CE, EU-MDR, 93/42/EEC, ISO 13485, RoHS, MDSAP, MHRA, NMPA, ANVISA, FSC, DOC, MDMA, and IEC electrical safety test reports. This is the widest certification coverage in the Fitconn catalogue, and for a distributor building multi-market distribution, it collapses years of regulatory groundwork into a purchase order.

MDSAP: The Certification That Signals Manufacturing Discipline

Among that list, one entry deserves specific attention. MDSAP — the Medical Device Single Audit Program — is a joint audit framework recognised by the regulatory authorities of Australia, Brazil, Canada, Japan, and the United States. A single MDSAP audit satisfies the quality management system requirements of all five jurisdictions simultaneously.

Obtaining MDSAP certification is not a paperwork exercise. It requires the manufacturer to submit to a comprehensive on-site audit covering management processes, design controls, production controls, purchasing controls, and device-specific processes — assessed against the combined requirements of five national regulators. Most small and mid-size Chinese medical device factories do not hold it, because the audit cost and the process discipline required are substantial.

For a buyer evaluating supplier credibility, MDSAP is a stronger signal than any product specification. It means an independent auditing body has examined the factory's actual operations against the standards of Health Canada, the US FDA, Brazil's ANVISA, Japan's MHLW, and Australia's TGA — and found them compliant.

Copper and Aluminium Where It Matters

The CNB69006 is a jet piston compressor nebulizer built around a copper and aluminium motor housed in a 100% ABS shell measuring 195 by 145 by 135 millimetres.

The motor material specification is worth examining, because it is where compressor nebulizers succeed or fail over a service life. Copper windings offer higher conductivity and better thermal tolerance than aluminium-only alternatives, and aluminium components dissipate heat efficiently. A compressor nebulizer runs a mechanical piston under load for ten to twenty minutes per session, multiple times daily, for years. Motors that overheat degrade; degraded motors lose pressure output; and lost pressure output means the nebulization rate drops below therapeutic threshold without any visible sign of failure.

Fitconn's own documentation notes plainly that the compressor generates heat during operation and that the airway interface warms from compressed airflow — both normal characteristics of piston compression. Stating this openly rather than omitting it is a small credibility marker: the manufacturer expects the device to be used heavily enough for the user to notice.

Performance Where the Numbers Count

The compressor delivers a liter flow exceeding 6.7 lpm, driving a maximum nebulization rate of ≥0.25 mL per minute — higher output than most portable units in this class. Operating pressure spans 9.5 to 19 PSI, with the internal compressor rated to 22 to 58 PSI. That pressure headroom is what maintains consistent nebulization as the medication cup depletes, a point where underpowered compressors lose output.

The particle spectrum runs 0.5 to 10 micrometres, broad enough to serve both upper-airway inflammation and deeper bronchial conditions. This range makes the CNB69006 versatile across medication types — corticosteroids, bronchodilators, saline solutions, and antibiotic aerosols all fall within its effective delivery envelope.

Sound output is rated ≤65 dB(A), with the attributes listing citing ≤58 dB(A) — either figure places it at or below normal conversation level for a mechanically driven piston compressor.

Why Jet Compression Still Matters

Fitconn's product documentation makes a clinical argument that is worth restating, because it explains why compressor nebulizers persist in a market increasingly crowded by mesh devices.

Jet nebulization provides therapy for patients who cannot use other inhalation modalities — metered-dose inhalers and dry-powder inhalers both require the patient to coordinate a deliberate, forceful inhalation with device actuation. Infants cannot do this. Patients in acute respiratory distress cannot. Elderly patients with cognitive impairment or reduced inspiratory force often cannot.

A jet nebulizer requires no patient coordination whatsoever. The medication is aerosolised continuously; the patient simply breathes. It also permits administration of large medication doses that inhalers cannot deliver, and releases no CFC propellants.

For the patient populations that need respiratory therapy most urgently, this is not a legacy technology. It is the only technology that works.

Packaging Built for Distribution

The CNB69006 ships one unit per colour box, six units per carton, with carton dimensions of 54 by 29.5 by 34.5 centimetres at 10.37 kilograms gross. Standard colourway is white and blue, with six accessories included covering multiple mask sizes for adult and paediatric use.

Logo, packaging, and graphic customisation are available at 1,000-piece MOQ, and the device carries a one-year warranty and online technical support.

Manufacturing Foundation

The CNB69006 is manufactured by Shenzhen Fitconn Technology Co., Ltd. — 21 years in medical device production, a 4.9 out of 5 store rating, a 23% reorder rate, and the number one ranking among household medical device factories on its platform. Fitconn offers OEM and ODM service, holds patent designs on select models, grants exclusive territory rights to major clients, and accepts third-party inspection.

Who Should Carry This Product

The CNB69006 is built for the distributor operating across multiple regulatory regions simultaneously — an importer serving Brazil and the EU, a group serving the UK and China, or a trading operation that needs one SKU it can legally ship anywhere without maintaining separate registered variants.

It also suits institutional and clinic procurement, where jet compression is preferred precisely because it works for patients who cannot manage inhalers, and where MDSAP certification frequently appears as a tender requirement rather than a nice-to-have.

The Final Word

Most nebulizers compete on particle size and noise level. The CNB69006 competes on where it is legally allowed to be sold. Fourteen certifications spanning the EU, UK, Brazil, China, and the MDSAP five-nation bloc represent an investment in regulatory infrastructure that most manufacturers in this price segment simply have not made. Combined with a copper-aluminium compressor engineered for sustained duty and a jet nebulization architecture that serves patients no inhaler can reach, this is a product built for buyers whose constraint is market access rather than unit cost.